NCT04056455View on ClinicalTrials.gov

A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 4, 2020

Primary Completion Date

April 20, 2022

Study Completion Date

April 20, 2022

Conditions
Renal ImpairmentHealthy Volunteers
Interventions
DRUG

Mobocertinib

Mobocertinib capsule.

Trial Locations (2)

32809

Orlando Clinical Research Center, Orlando

33014

Clinical Pharmacology of Miami, Hialeah

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY